Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Xpeng Inc - ADR — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Xpeng Inc - ADR trades at $9.42 (market cap $9.24B). The key difference: Xpeng Inc - ADR is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Xpeng Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Xpeng Inc - ADR for 81 Days on average.
| ORKA | XPEV | |
|---|---|---|
Market Cap | $5.18B | $9.24B |
Volume | 490,798 | 6,669,510 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $28.07 |
52-Week Low | $26.19 | $9.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $4.31B | $11.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XPeng (XPEV) trades at $9.75, up 0.93% on the day, amid a bearish technical signal and mixed financial performance. The company reported strong revenue growth to $76.72 billion in 2025 (XPeng earnings report, 2025) but continues to post net losses, with a negative net income margin of -4.14%. Recent news highlights expansion into AI and robotics, including the launch of the G9L SUV and humanoid robot production, signaling strategic diversification beyond electric vehicles.
The investment outlook balances high growth potential against persistent profitability challenges. Analyst consensus is bullish with a $17.55 price target (MarketBeat, 2026), but risks include intense EV competition, macroeconomic pressures in China, and the capital-intensive nature of new technology ventures. Shareholder value hinges on achieving sustained profitability and successful execution of its Physical AI initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
